Search Within

Charles Rudin

  1. "2024"
Formats
  1. Journal Article (29)
  2. Meeting Abstract (16)
  3. Review (2)
  4. Editorial (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (48)
  2. Department of Medicine (48)
  3. GSK Faculty (48)
  4. Solid Tumor Oncology Division (48)
  5. Thoracic Oncology (48)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (38)

More Groups

People
  1. Alvaro Quintanal Villalonga (14)
  2. Bob Li (8)
  3. Parvathy Manoj (8)
  4. Elisa De Stanchina (7)
  5. Ester Redin Resano (7)
  6. Joseph Chan (7)

More People

Years
  1. 2024 (48)
Publications
  1. Journal of Clinical Oncology (10)
  2. Journal of Thoracic Oncology (7)
  3. Annals of Oncology (4)
  4. JCO Precision Oncology (3)
  5. Nature (3)
  6. Science Advances (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. Elsevier Inc. (9)
  3. American Association for Cancer Research (4)
  4. Cell Press (4)
  5. Nature Publishing Group (4)
  6. Oxford University Press (4)

More Publishers

Results (48)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intracranial response in patients (pts) with baseline (BL) brain metastases (BM) and extensive-stage (ES) small cell lung cancer (SCLC) treated with ifinatamab deruxtecan (I-DXd) in the IDeate-Lung01 study
    Meeting Abstract

    Johnson, M. L.; Simoes da Rocha, P. F.; Kim, Y. J.; Chen, Y.; Paz-Ares, L. G.; Girard, N.; Hann, C. L.; Nishio, M.; Ahn, M. J.; Qian, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • IDeate-Lung03: A Phase Ib/II study of ifinatamab deruxtecan (I-DXd) plus atezolizumab (atezo) with or without carboplatin (carbo) as first-line (1L) induction or maintenance in patients (pts) with extensive stage (ES) small cell lung cancer (SCLC)
    Meeting Abstract

    Rudin, C. M.; Salkeni, M. A.; Gutierrez, M.; Hayashi, H.; Thompson, J.; Arca, M.; Hirose, D.; Singh, J.; Turner, J.; Zhang, Y.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Lurbinectedin synergizes with selinexor by inhibiting DNA damage repair and enhancing immune cell infiltration in neuroendocrine lung tumors
    Meeting Abstract

    Redin, E.; Manoj, P.; Qiu, J.; Zhong, H.; Vural, S.; Zhan, Y.; Koche, R.; Socci, N.; DeStanchina, E.; Rudin, C. M.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • SMARCA4 controls state plasticity in SCLC through regulation of neuroendocrine transcription factors and REST splicing
    Meeting Abstract

    Redin, E.; Sridhar, H.; Zhan, Y.; Pereira Mello, B.; Zhong, H.; Manoj, P.; Linkov, I.; Qiu, J.; Koche, R. P.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Targeting TROP-2 in diffuse pleural mesothelioma
    Meeting Abstract

    Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Advancing global health equity in oncology clinical trial access
    Editorial

    Bloomberg New Economy International Cancer Coalition; McKinsey Cancer Center; Cure4Cancer
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Automated real-world data integration improves cancer outcome prediction
    Journal Article

    Jee, J.; Fong, C.; Pichotta, K.; Tran, T. N.; Luthra, A.; Waters, M.; Fu, C.; Altoe, M.; Liu, S. Y.; Maron, S. B.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Lung cancer research and treatment: Global perspectives and strategic calls to action
    Review

    Meyer, M. L.; Peters, S.; Mok, T. S.; Lam, S.; Yang, P. C.; Aggarwal, C.; Brahmer, J.; Dziadziuszko, R.; Felip, E.; Ferris, A.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
    Journal Article

    Skoulidis, F.; Araujo, H. A.; Do, M. T.; Qian, Y.; Sun, X.; Cobo, A. G.; Le, J. T.; Montesion, M.; Palmer, R.; Jahchan, N.; more...
    Nature (2024)

    Fulltext@MSK | Save